Origins of DLBCL genes

Tier 1, high-confidence DLBCL genes

125 total

Gene Summary First DLBCL study Other entities QC result
ACTB Tier 1 GE1, aSHM Lohr et al 2,3
ACTG1 Tier 1 GE4, aSHM Fan et al 5–7
ARID1A Tier 1 GE8, FE9 Zhang et al 3,10–12
ATM Tier 1 GE13, FE14 Reddy et al 15,16
B2M Tier 1 GE17, FE18 Morin et al 19,20
BCL10 Tier 1 GE17, FE21 Morin et al 7,22
BCL2 Tier 1 GE23, aSHM Tanaka et al 17,24,25
BCL6 Tier 1 GE17, FE26, aSHM Morin et al 2,11
BCL7A Tier 1 GE17, FE27, aSHM Morin et al 10,20,28
BIRC6 Tier 1 GE13 Reddy et al 25
BRAF Tier 1 GE29, FE30 Tiacci et al 11
BTG1 Tier 1 GE17, FE31, aSHM Morin et al 2,24,25
BTG2 Tier 1 GE17, aSHM Morin et al 2,11
BTK Tier 1 GE32, FE33 Albuquerque et al 10
CARD11 Tier 1 GE34, FE34 Lenz et al 17,35,36
CCND3 Tier 1 GE17, FE37 Morin et al 5,38,39
CD58 Tier 1 GE17, FE18 Morin et al 40
CD70 Tier 1 GE17, FE41 Morin et al 22
CD79B Tier 1 GE42, FE42 Davis et al 2,43
CD83 Tier 1 GE44, aSHM Morin et al 22,43,45
CDKN2A Tier 1 GE44, FE46 Morin et al 7,28
CIITA Tier 1 GE17, FE47, aSHM Morin et al 47
CREBBP Tier 1 GE48, FE48 Pasqualucci et al 11,45,49
CXCR4 Tier 1 GE50, FE51, aSHM Khodabakhshi et al 10,43
DDX3X Tier 1 GE13, FE52 Reddy et al 37,53
DTX1 Tier 1 GE8, aSHM Zhang et al 11,12,54
DUSP2 Tier 1 GE1, aSHM Lohr et al 2,45
EBF1 Tier 1 GE55, FE56, aSHM Bohle et al 2,20,57
EEF1A1 Tier 1 GE58 Chapuy et al 6,20
EP300 Tier 1 GE48, FE48 Pasqualucci et al 12
ETS1 Tier 1 GE17, aSHM Morin et al 43
ETV6 Tier 1 GE1, FE59, aSHM Lohr et al
EZH2 Tier 1 GE60, FE61 Morin et al 11,53
FAS Tier 1 GE62, FE63 Scholl et al 7,17
FBXO11 Tier 1 GE64, FE65 Arthur et al 39,49
FBXW7 Tier 1 GE8, FE66 Zhang et al
FOXO1 Tier 1 GE17, FE67 Morin et al 37,45
GNA13 Tier 1 GE17, FE68 Morin et al 11,20
GNAI2 Tier 1 GE44, FE68 Morin et al 2,28
GRB2 Tier 1 GE69 Pasqualucci et al
GRHPR Tier 1 GE70, aSHM Schmitz et al
HIST1H1B Tier 1 GE58, aSHM Chapuy et al 10,25
HIST1H1C Tier 1 GE17, aSHM Morin et al 43
HIST1H1D Tier 1 GE44, aSHM Morin et al 10,38
HIST1H1E Tier 1 GE1, aSHM Lohr et al 10,20,28
HIST1H2AC Tier 1 GE44, aSHM Morin et al 10
HIST1H2AM Tier 1 GE58, aSHM Chapuy et al 10,43
HIST1H2BC Tier 1 GE1, aSHM Lohr et al 10,53
HIST1H2BK Tier 1 GE8, aSHM Zhang et al 12,43
HIST1H3B Tier 1 GE1, aSHM Lohr et al 20
HIST2H2BE Tier 1 GE58, aSHM Chapuy et al
HLA-A Tier 1 GE1, FE71 Lohr et al 5
HLA-B Tier 1 GE1, FE71 Lohr et al 3
HLA-C Tier 1 GE58, FE71 Chapuy et al 54
HLA-DMB Tier 1 GE6 Hubschmann et al
HNRNPU Tier 1 GE13 Reddy et al 43
HVCN1 Tier 1 GE58 Chapuy et al 10
IKZF3 Tier 1 GE17, FE72 Morin et al 43
IL4R Tier 1 GE45, FE73, aSHM Duns et al 73
IRF4 Tier 1 GE17, aSHM Morin et al 2,53
IRF8 Tier 1 GE17, FE74, aSHM Morin et al 43,53
ITPKB Tier 1 GE70, FE75, aSHM Schmitz et al 2,20
JUNB Tier 1 GE1 Lohr et al 53 PASS
KLF2 Tier 1 GE69, aSHM Pasqualucci et al 2,5,38
KLHL14 Tier 1 GE8, FE76 Zhang et al
KLHL6 Tier 1 GE17, FE77, aSHM Morin et al 78
KMT2C Tier 1 GE8 Zhang et al 25,79,80
KMT2D Tier 1 GE17, FE81 Morin et al 5,12,15,28
KRAS Tier 1 GE1, FE82 Lohr et al
LRRN3 Tier 1 GE8 Zhang et al 25
LTB Tier 1 GE58, aSHM Chapuy et al 2,5
MEF2B Tier 1 GE17, FE83, aSHM Morin et al 15
MEF2C Tier 1 GE6, aSHM Hubschmann et al
MGA Tier 1 GE13, FE84 Reddy et al 38
MIR142 Tier 1 GE85, FE86, aSHM Kwanhian et al 28
MPEG1 Tier 1 GE44 Morin et al
MS4A1 Tier 1 GE87, FE87, aSHM Rushton et al 53
MTOR Tier 1 GE8, FE88 Zhang et al 43
MYC Tier 1 GE89, FE90, aSHM Pasqualucci et al 38,45,91
MYD88 Tier 1 GE92, FE92 Ngo et al 2,36
NFKBIA Tier 1 GE93, FE94 Thomas et al 3,22
NFKBIE Tier 1 GE95, FE96 Morin et al 19,97
NFKBIZ Tier 1 GE95, FE64, aSHM Morin et al
NOL9 Tier 1 GE70 Schmitz et al 7
NOTCH1 Tier 1 GE69, FE98 Pasqualucci et al 11,12,15
NOTCH2 Tier 1 GE8, FE99 Zhang et al 12,15
OSBPL10 Tier 1 GE8, aSHM Zhang et al
P2RY8 Tier 1 GE1, FE68 Lohr et al 2,68
PIM1 Tier 1 GE89, FE100, aSHM Pasqualucci et al 2,24,45
PIM2 Tier 1 GE13, aSHM Reddy et al 20
POU2AF1 Tier 1 GE58, FE101, aSHM Chapuy et al 10
POU2F2 Tier 1 GE1, FE102 Lohr et al 10
PRDM1 Tier 1 GE103, FE103 Pasqualucci et al
PTEN Tier 1 GE13, FE104 Reddy et al 11
PTPN6 Tier 1 GE13, FE105 Reddy et al PASS
RB1 Tier 1 GE44, FE106 Morin et al 79
RFX7 Tier 1 GE64, FE107 Arthur et al 28
RHOA Tier 1 GE8, FE108 Zhang et al 39
RRAGC Tier 1 GE109, FE109 Okosun et al
S1PR2 Tier 1 GE17, FE68, aSHM Morin et al 2,68
SETD1B Tier 1 GE32, FE[@] Albuquerque et al
SF3B1 Tier 1 GE13, FE110 Reddy et al 11
SGK1 Tier 1 GE17, FE111, aSHM Morin et al 45
SIN3A Tier 1 GE58 Chapuy et al 12,28
SMARCA4 Tier 1 GE13, FE112 Reddy et al 10,39,113
SOCS1 Tier 1 GE17, FE114, aSHM Morin et al 2,115
SPEN Tier 1 GE32 Albuquerque et al 12,25
STAT3 Tier 1 GE17, FE116 Morin et al
STAT6 Tier 1 GE117, FE118 Yildiz et al 119
TAF1 Tier 1 GE44 Morin et al 7
TBL1XR1 Tier 1 GE1, FE120 Lohr et al 2,12
TET2 Tier 1 GE32, FE121 Albuquerque et al 57
TMEM30A Tier 1 GE17, FE122 Morin et al
TMSB4X Tier 1 GE13, aSHM Reddy et al 2
TNFAIP3 Tier 1 GE123, FE123 Compagno et al 2,124,125
TNFRSF14 Tier 1 GE17, FE[@] Morin et al 7,126
TOX Tier 1 GE13 Reddy et al
TP53 Tier 1 GE17, FE127 Morin et al 12,15,75,128
UBE2A Tier 1 GE1 Lohr et al 20
WEE1 Tier 1 GE70 Schmitz et al 20
XPO1 Tier 1 GE129, FE130 Mareschal et al 131
ZC3H12A Tier 1 GE58, FE132 Chapuy et al
ZFP36L1 Tier 1 GE17, aSHM Morin et al 20,43
ZNF292 Tier 1 GE13 Reddy et al
ZNF608 Tier 1 GE44 Morin et al 10

Tier 2, low-confidence DLBCL genes

210 total

Gene Summary First DLBCL study Other entities QC result
ABI3BP Tier 2 GE44 Morin et al PASS
ADAMTS1 Tier 2 GE6 Hubschmann et al PASS
ADAMTSL3 Tier 2 GE69 Pasqualucci et al
AICDA Tier 2 GE64, aSHM Arthur et al
AKAP8 Tier 2 GE69 Pasqualucci et al
ANKLE2 Tier 2 GE69 Pasqualucci et al
ANKRD12 Tier 2 GE6 Hubschmann et al PASS
ANKRD17 Tier 2 GE8 Zhang et al
ARAP2 Tier 2 GE44 Morin et al
ARID5B Tier 2 GE13 Reddy et al 54 PASS
ASXL3 Tier 2 GE32 Albuquerque et al
ATR Tier 2 GE13 Reddy et al PASS
BCL11A Tier 2 GE58, aSHM Chapuy et al
BCL2L10 Tier 2 GE69 Pasqualucci et al
BCR Tier 2 GE1 Lohr et al
BIRC3 Tier 2 GE64, aSHM Arthur et al 15,45,124
BLK Tier 2 GE, aSHM
BRINP3 Tier 2 GE13 Reddy et al PASS
BRSK1 Tier 2 GE69 Pasqualucci et al
BTBD3 Tier 2 GE8 Zhang et al
C12orf35 Tier 2 GE69 Pasqualucci et al
CADPS2 Tier 2 GE6 Hubschmann et al PASS
CAMTA1 Tier 2 GE69 Pasqualucci et al
CASP8 Tier 2 GE13 Reddy et al
CD22 Tier 2 GE13 Reddy et al PASS
CD274 Tier 2 GE17 Morin et al
CD36 Tier 2 GE69 Pasqualucci et al
CD44 Tier 2 GE64, aSHM Arthur et al
CD74 Tier 2 GE64, aSHM Arthur et al
CDH9 Tier 2 GE44 Morin et al PASS
CEP164 Tier 2 GE32 Albuquerque et al
CNOT2 Tier 2 GE6 Hubschmann et al PASS
CNTNAP5 Tier 2 GE44 Morin et al PASS
COQ7 Tier 2 GE58 Chapuy et al PASS
CPS1 Tier 2 GE1 Lohr et al
CRIP1 Tier 2 GE58 Chapuy et al PASS
CXCR5 Tier 2 GE70 Schmitz et al 53
CYTSB Tier 2 GE69 Pasqualucci et al
DAZAP1 Tier 2 GE19 Pararajalingam et al
DCHS1 Tier 2 GE69 Pasqualucci et al
DDX10 Tier 2 GE8 Zhang et al
DHX16 Tier 2 GE6 Hubschmann et al PASS
DNAH5 Tier 2 GE44 Morin et al 38 PASS
DNM2 Tier 2 GE6 Hubschmann et al PASS
DNMT3B Tier 2 GE32 Albuquerque et al
DOCK1 Tier 2 GE58 Chapuy et al PASS
DPYD Tier 2 GE69 Pasqualucci et al
DSC3 Tier 2 GE69 Pasqualucci et al
DSEL Tier 2 GE44 Morin et al
DSG4 Tier 2 GE44 Morin et al PASS
DUSP27 Tier 2 GE69 Pasqualucci et al
DUSP9 Tier 2 GE69 Pasqualucci et al
EIF2AK3 Tier 2 GE70, aSHM Schmitz et al
ERAP2 Tier 2 GE32 Albuquerque et al
EZR Tier 2 GE, aSHM 5
FAM102A Tier 2 GE, aSHM
FANK1 Tier 2 GE, aSHM
FAT2 Tier 2 GE17 Morin et al
FAT4 Tier 2 GE44 Morin et al 49,79 PASS
FBXO31 Tier 2 GE69 Pasqualucci et al
FCRL3 Tier 2 GE, aSHM
FNBP1 Tier 2 GE, aSHM
FOXC1 Tier 2 GE70 Schmitz et al
FOXP1 Tier 2 GE13, aSHM Reddy et al PASS
FUBP1 Tier 2 GE13 Reddy et al PASS
GABRA1 Tier 2 GE1 Lohr et al
GABRA2 Tier 2 GE58 Chapuy et al
GOLGA5 Tier 2 GE13 Reddy et al PASS
GPC5 Tier 2 GE70 Schmitz et al
GSG2 Tier 2 GE70 Schmitz et al
H1FOO Tier 2 GE1 Lohr et al
HDAC7 Tier 2 GE44 Morin et al PASS
HIST1H2AG Tier 2 GE44 Morin et al 10,12,43 PASS
HIST1H2AL Tier 2 GE1 Lohr et al
HIST1H2BO Tier 2 GE1 Lohr et al
HIST1H3A Tier 2 GE1 Lohr et al
HLA-DMA Tier 2 GE58 Chapuy et al
HMGB1 Tier 2 GE69 Pasqualucci et al
HNF1B Tier 2 GE69 Pasqualucci et al
HNRNPD Tier 2 GE13 Reddy et al
HNRNPH1 Tier 2 GE19 Pararajalingam et al
ID3 Tier 2 GE70 Schmitz et al 7,39
IFNGR1 Tier 2 GE44 Morin et al PASS
IGLL5 Tier 2 GE58, aSHM Chapuy et al 5,22,43
IKBKB Tier 2 GE13 Reddy et al 3,124 PASS
IKBKE Tier 2 GE6 Hubschmann et al PASS
IL16 Tier 2 GE13 Reddy et al
IL6 Tier 2 GE58 Chapuy et al PASS
INO80 Tier 2 GE13 Reddy et al
IRF1 Tier 2 GE6, aSHM Hubschmann et al PASS
JAK1 Tier 2 GE13 Reddy et al 53
JAK3 Tier 2 GE13 Reddy et al
KCMF1 Tier 2 GE13 Reddy et al PASS
KDM2B Tier 2 GE69 Pasqualucci et al
KLHL21 Tier 2 GE70 Schmitz et al
KRTAP5-5 Tier 2 GE1 Lohr et al
LAMA5 Tier 2 GE70 Schmitz et al
LAPTM5 Tier 2 GE6, aSHM Hubschmann et al PASS
LCOR Tier 2 GE[@]
LPP Tier 2 GE64, aSHM Arthur et al
LRP12 Tier 2 GE6 Hubschmann et al PASS
LYN Tier 2 GE58 Chapuy et al PASS
MAGEC3 Tier 2 GE69 Pasqualucci et al
MAGT1 Tier 2 GE13 Reddy et al PASS
MALAT1 Tier 2 GE64, aSHM Arthur et al
MAP2K1 Tier 2 GE133 Shin et al 134
MCL1 Tier 2 GE13 Reddy et al 43,45 PASS
MECOM Tier 2 GE13 Reddy et al PASS
MED12L Tier 2 GE69 Pasqualucci et al
MET Tier 2 GE13 Reddy et al PASS
MIR155HG Tier 2 GE, aSHM
MPDZ Tier 2 GE44 Morin et al 20 PASS
MSH6 Tier 2 GE13 Reddy et al PASS
MTMR8 Tier 2 GE69 Pasqualucci et al
MYBPC2 Tier 2 GE70 Schmitz et al
MYO1G Tier 2 GE69 Pasqualucci et al
MYOM2 Tier 2 GE69 Pasqualucci et al
NAV1 Tier 2 GE58 Chapuy et al
NCOA3 Tier 2 GE, aSHM
NEAT1 Tier 2 GE64, aSHM Arthur et al
NF1 Tier 2 GE8 Zhang et al
NLRP5 Tier 2 GE44 Morin et al PASS
ODZ2 Tier 2 GE44 Morin et al PASS
OFD1 Tier 2 GE69 Pasqualucci et al
OR6K3 Tier 2 GE1 Lohr et al
P2RX5 Tier 2 GE44, aSHM Morin et al PASS
PAPOLG Tier 2 GE70 Schmitz et al
PASD1 Tier 2 GE1 Lohr et al
PASK Tier 2 GE44 Morin et al PASS
PAX5 Tier 2 GE89, aSHM Pasqualucci et al
PCDHB11 Tier 2 GE44 Morin et al PASS
PCDHB6 Tier 2 GE1 Lohr et al
PCLO Tier 2 GE1 Lohr et al
PDGFC Tier 2 GE1 Lohr et al
PDS5B Tier 2 GE44 Morin et al 6 PASS
PIK3CD Tier 2 GE8 Zhang et al
PIK3R1 Tier 2 GE8 Zhang et al 43
PMS1 Tier 2 GE69 Pasqualucci et al
PNPO Tier 2 GE6 Hubschmann et al PASS
PPP2R5A Tier 2 GE69 Pasqualucci et al
PRKCB Tier 2 GE44 Morin et al PASS
PRKDC Tier 2 GE70 Schmitz et al 6
PRPS1 Tier 2 GE58 Chapuy et al PASS
PTPN21 Tier 2 GE1 Lohr et al
PTPRD Tier 2 GE2 Dreval et al 7
RAC2 Tier 2 GE6 Hubschmann et al PASS
RAPGEF1 Tier 2 GE17 Morin et al
RASGEF1A Tier 2 GE69 Pasqualucci et al
RBP3 Tier 2 GE1 Lohr et al 11
RCC Tier 2 GE, aSHM
RFTN1 Tier 2 GE64, aSHM Arthur et al 45
RFXAP Tier 2 GE
RGAG1 Tier 2 GE69 Pasqualucci et al
RHEX Tier 2 GE64, aSHM Arthur et al
RHOH Tier 2 GE89, aSHM Pasqualucci et al
RUBCNL Tier 2 GE, aSHM
S1PR1 Tier 2 GE1 Lohr et al 19
SAMD9L Tier 2 GE44 Morin et al PASS
SEL1L3 Tier 2 GE70, aSHM Schmitz et al
SEPTIN9 Tier 2 GE, aSHM
SERPINA1 Tier 2 GE69 Pasqualucci et al
SERPINA9 Tier 2 GE64, aSHM Arthur et al
SETD2 Tier 2 GE8 Zhang et al
SETD5 Tier 2 GE13 Reddy et al 75 PASS
SIAH2 Tier 2 GE6 Hubschmann et al 20 PASS
SLC34A2 Tier 2 GE6 Hubschmann et al PASS
SLC38A8 Tier 2 GE1 Lohr et al
SLITRK6 Tier 2 GE1 Lohr et al
SMARCA1 Tier 2 GE69 Pasqualucci et al
SMEK1 Tier 2 GE8 Zhang et al
SRPX Tier 2 GE1 Lohr et al
SRRM2 Tier 2 GE44 Morin et al 22 PASS
ST6GAL1 Tier 2 GE64, aSHM Arthur et al
STAT5B Tier 2 GE13 Reddy et al 75
SYN2 Tier 2 GE1 Lohr et al
SYPL1 Tier 2 GE44 Morin et al PASS
TAP1 Tier 2 GE70 Schmitz et al
TBC1D4 Tier 2 GE64, aSHM Arthur et al
TBP Tier 2 GE1 Lohr et al
TCL1A Tier 2 GE13, aSHM Reddy et al 28
TGFBR2 Tier 2 GE13 Reddy et al PASS
TIPARP Tier 2 GE13 Reddy et al PASS
TLL2 Tier 2 GE69 Pasqualucci et al
TLR2 Tier 2 GE58 Chapuy et al 15 PASS
TMSL3 Tier 2 GE1 Lohr et al
TNF Tier 2 GE1 Lohr et al
TRAF3 Tier 2 GE69 Pasqualucci et al 124,135
TRAF6 Tier 2 GE6 Hubschmann et al PASS
TRIP12 Tier 2 GE
TSC22D1 Tier 2 GE69 Pasqualucci et al
UBE2J1 Tier 2 GE70, aSHM Schmitz et al
UBR5 Tier 2 GE32 Albuquerque et al 19
UHRF1BP1 Tier 2 GE32 Albuquerque et al
UNC5B Tier 2 GE6 Hubschmann et al PASS
UNC5C Tier 2 GE1 Lohr et al
UNC5D Tier 2 GE1 Lohr et al
USP7 Tier 2 GE64 Arthur et al 28
VAX1 Tier 2 GE1 Lohr et al
WDFY3 Tier 2 GE44 Morin et al PASS
WNK1 Tier 2 GE6 Hubschmann et al 38,57 PASS
XBP1 Tier 2 GE, aSHM
YY1 Tier 2 GE13 Reddy et al PASS
ZCCHC7 Tier 2 GE64, aSHM Arthur et al
ZEB2 Tier 2 GE13 Reddy et al
ZFX Tier 2 GE13 Reddy et al PASS
ZNF217 Tier 2 GE6 Hubschmann et al 20 PASS
ZNF385B Tier 2 GE1 Lohr et al
ZNF423 Tier 2 GE58 Chapuy et al PASS
ZNF521 Tier 2 GE69 Pasqualucci et al
ZWILCH Tier 2 GE69 Pasqualucci et al

Tier 3, retired DLBCL genes

387 total

Gene Summary First DLBCL study Other entities QC result
ABCA3 Tier 3 GE8 Zhang et al 15
ABCA4 Tier 3 GE8 Zhang et al
ABCB1 Tier 3 GE4 Fan et al
ACE Tier 3 GE8 Zhang et al 11
ACSM3 Tier 3 GE8 Zhang et al
ACSS2 Tier 3 GE8 Zhang et al
ACSS3 Tier 3 GE8 Zhang et al
ACTN1 Tier 3 GE8 Zhang et al
ADAM2 Tier 3 GE8 Zhang et al
ADAMTS15 Tier 3 GE8 Zhang et al
ADH7 Tier 3 GE8 Zhang et al
AFAP1L2 Tier 3 GE8 Zhang et al
AGA Tier 3 GE4 Fan et al
AHR Tier 3 GE8 Zhang et al
AKAP9 Tier 3 GE8 Zhang et al
ALAS1 Tier 3 GE8 Zhang et al
ALDH1L2 Tier 3 GE8 Zhang et al
AMAC1 Tier 3 GE8 Zhang et al
AMIGO3 Tier 3 GE8 Zhang et al
AMPH Tier 3 GE8 Zhang et al
ANK2 Tier 3 GE8 Zhang et al 79
ANKRD44 Tier 3 GE8 Zhang et al
ANTXR1 Tier 3 GE8 Zhang et al
AP1G2 Tier 3 GE8 Zhang et al
APBB1 Tier 3 GE8 Zhang et al
APC Tier 3 GE8 Zhang et al
APMAP Tier 3 GE4 Fan et al
APOA5 Tier 3 GE8 Zhang et al
APP Tier 3 GE8 Zhang et al
ARID1B Tier 3 GE13 Reddy et al FAIL
ATIC Tier 3 GE8 Zhang et al
ATP10A Tier 3 GE8 Zhang et al
ATP1A2 Tier 3 GE8 Zhang et al
ATP2A3 Tier 3 GE8 Zhang et al
ATP6V0A1 Tier 3 GE4 Fan et al
B4GALNT2 Tier 3 GE8 Zhang et al
BAZ1A Tier 3 GE8 Zhang et al
BCAT2 Tier 3 GE8 Zhang et al
BLM Tier 3 GE8 Zhang et al
BMPR1A Tier 3 GE8 Zhang et al
BRCA1 Tier 3 GE4 Fan et al
BRCA2 Tier 3 GE8 Zhang et al
BRD4 Tier 3 GE8 Zhang et al 11
BSCL2 Tier 3 GE8 Zhang et al
BTAF1 Tier 3 GE8 Zhang et al
C9 Tier 3 GE8 Zhang et al
CAD Tier 3 GE8 Zhang et al 11
CAPN5 Tier 3 GE8 Zhang et al
CAPN7 Tier 3 GE8 Zhang et al
CBLB Tier 3 GE13 Reddy et al FAIL
CBX3 Tier 3 GE4 Fan et al
CCDC132 Tier 3 GE8 Zhang et al
CCDC46 Tier 3 GE8 Zhang et al
CCDC97 Tier 3 GE8 Zhang et al
CCL4 Tier 3 GE58 Chapuy et al FAIL
CCNF Tier 3 GE8 Zhang et al 136
CDC123 Tier 3 GE8 Zhang et al
CDC73 Tier 3 GE13 Reddy et al 11 FAIL
CDH1 Tier 3 GE4 Fan et al
CDH10 Tier 3 GE8 Zhang et al
CDH7 Tier 3 GE8 Zhang et al
CDH8 Tier 3 GE13 Reddy et al 79 FAIL
CDK3 Tier 3 GE8 Zhang et al
CDKN1A Tier 3 GE4 Fan et al
CECR1 Tier 3 GE8 Zhang et al
CELSR2 Tier 3 GE8 Zhang et al
CGN Tier 3 GE4 Fan et al
CHD1 Tier 3 GE13 Reddy et al FAIL
CHD3 Tier 3 GE8 Zhang et al
CHEK2 Tier 3 GE4 Fan et al
CHRM5 Tier 3 GE8 Zhang et al
CHST2 Tier 3 GE13 Reddy et al FAIL
CIC Tier 3 GE8 Zhang et al
CNGA4 Tier 3 GE8 Zhang et al
CNOT6 Tier 3 GE8 Zhang et al
CNP Tier 3 GE8 Zhang et al
CNTN6 Tier 3 GE8 Zhang et al
COL5A2 Tier 3 GE8 Zhang et al
CORO2A Tier 3 GE8 Zhang et al
CORO7 Tier 3 GE8 Zhang et al
CRELD2 Tier 3 GE8 Zhang et al
CRTC3 Tier 3 GE8 Zhang et al
CSNK1A1 Tier 3 GE4 Fan et al
CSNK2A1 Tier 3 GE4 Fan et al
CST7 Tier 3 GE8 Zhang et al
CTNNA3 Tier 3 GE8 Zhang et al
CYP24A1 Tier 3 GE8 Zhang et al
CYP2C18 Tier 3 GE8 Zhang et al
CYYR1 Tier 3 GE4 Fan et al
DCAF6 Tier 3 GE13 Reddy et al FAIL
DDB1 Tier 3 GE8 Zhang et al
DGCR8 Tier 3 GE4 Fan et al
DHX33 Tier 3 GE4 Fan et al
DIAPH3 Tier 3 GE8 Zhang et al
DICER1 Tier 3 GE13 Reddy et al FAIL
DIP2B Tier 3 GE8 Zhang et al
DLGAP1 Tier 3 GE8 Zhang et al 11
DMXL1 Tier 3 GE8 Zhang et al
DNMT3A Tier 3 GE13 Reddy et al FAIL
DOCK2 Tier 3 GE8 Zhang et al
DOCK5 Tier 3 GE4 Fan et al
DOLK Tier 3 GE8 Zhang et al
DSC2 Tier 3 GE8 Zhang et al
DSCAML1 Tier 3 GE8 Zhang et al
DSG2 Tier 3 GE8 Zhang et al
DSP Tier 3 GE8 Zhang et al
DUOXA2 Tier 3 GE8 Zhang et al
DUPD1 Tier 3 GE8 Zhang et al
DYNC1H1 Tier 3 GE8 Zhang et al
DYNC1I1 Tier 3 GE8 Zhang et al
ECGF1 Tier 3 GE8 Zhang et al
ECT2L Tier 3 GE4 Fan et al
EGFR Tier 3 GE4 Fan et al
EPHA3 Tier 3 GE8 Zhang et al
EPHA5 Tier 3 GE8 Zhang et al
EPHA7 Tier 3 GE8 Zhang et al 53
ERBB3 Tier 3 GE8 Zhang et al
ERN2 Tier 3 GE8 Zhang et al
ETNPPL Tier 3 GE8 Zhang et al
EXTL3 Tier 3 GE8 Zhang et al
FAIM Tier 3 GE4 Fan et al
FAM161A Tier 3 GE4 Fan et al
FAM38B Tier 3 GE44 Morin et al FAIL
FAM62C Tier 3 GE8 Zhang et al
FANCD2 Tier 3 GE8 Zhang et al
FGD3 Tier 3 GE8 Zhang et al
FGFR1 Tier 3 GE8 Zhang et al
FIGN Tier 3 GE8 Zhang et al
FLNA Tier 3 GE4 Fan et al
FLNC Tier 3 GE8 Zhang et al
FLT1 Tier 3 GE4 Fan et al
FMO2 Tier 3 GE8 Zhang et al
FN1 Tier 3 GE4 Fan et al
FNDC1 Tier 3 GE44 Morin et al FAIL
FRMPD1 Tier 3 GE8 Zhang et al
FUT5 Tier 3 GE58 Chapuy et al FAIL
FZD1 Tier 3 GE4 Fan et al
GABRG1 Tier 3 GE8 Zhang et al
GAK Tier 3 GE6 Hubschmann et al FAIL
GATA2 Tier 3 GE4 Fan et al
GATA3 Tier 3 GE4 Fan et al
GCN1L1 Tier 3 GE8 Zhang et al
GJA8 Tier 3 GE8 Zhang et al
GJB4 Tier 3 GE8 Zhang et al
GNAS Tier 3 GE13 Reddy et al FAIL
GOPC Tier 3 GE8 Zhang et al
GPD2 Tier 3 GE8 Zhang et al
GPR133 Tier 3 GE8 Zhang et al
GPR15 Tier 3 GE8 Zhang et al
GREM2 Tier 3 GE8 Zhang et al
GRIA2 Tier 3 GE8 Zhang et al
GRM5 Tier 3 GE8 Zhang et al
H6PD Tier 3 GE8 Zhang et al
HACE1 Tier 3 GE8 Zhang et al
HCK Tier 3 GE8 Zhang et al
HFE Tier 3 GE4 Fan et al
HIPK3 Tier 3 GE8 Zhang et al
HIST1H4I Tier 3 GE8 Zhang et al
HK3 Tier 3 GE8 Zhang et al
HLA-DQA1 Tier 3 GE6 Hubschmann et al FAIL
HLA-DRB1 Tier 3 GE4 Fan et al
HNRNPR Tier 3 GE8 Zhang et al
HRAS Tier 3 GE13 Reddy et al 38 FAIL
HSF2 Tier 3 GE8 Zhang et al
IDH1 Tier 3 GE8 Zhang et al
IER2 Tier 3 GE44 Morin et al FAIL
IL6ST Tier 3 GE4 Fan et al
INSC Tier 3 GE8 Zhang et al
INTS6 Tier 3 GE8 Zhang et al
IQGAP1 Tier 3 GE8 Zhang et al
IQUB Tier 3 GE8 Zhang et al
ITGA2 Tier 3 GE8 Zhang et al
ITGA8 Tier 3 GE8 Zhang et al
ITGB3 Tier 3 GE8 Zhang et al
ITGB4 Tier 3 GE4 Fan et al
ITPR1 Tier 3 GE4 Fan et al
JAG1 Tier 3 GE8 Zhang et al
JAKMIP2 Tier 3 GE8 Zhang et al
KCNA3 Tier 3 GE8 Zhang et al
KCNAB3 Tier 3 GE8 Zhang et al
KCNJ6 Tier 3 GE8 Zhang et al
KCNT2 Tier 3 GE8 Zhang et al
KDR Tier 3 GE8 Zhang et al
KIF21B Tier 3 GE8 Zhang et al
KIT Tier 3 GE8 Zhang et al
KITLG Tier 3 GE4 Fan et al
KLB Tier 3 GE8 Zhang et al
KLC3 Tier 3 GE8 Zhang et al
KLF4 Tier 3 GE8 Zhang et al
KLRC4 Tier 3 GE4 Fan et al
KRT6A Tier 3 GE8 Zhang et al
LEPR Tier 3 GE4 Fan et al
LEPREL1 Tier 3 GE8 Zhang et al
LIFR Tier 3 GE8 Zhang et al
LILRA2 Tier 3 GE8 Zhang et al
LIN54 Tier 3 GE13 Reddy et al FAIL
LIN7C Tier 3 GE8 Zhang et al
LPHN2 Tier 3 GE8 Zhang et al
LRAP Tier 3 GE8 Zhang et al
LRIG3 Tier 3 GE8 Zhang et al
LRP1 Tier 3 GE8 Zhang et al
LRP10 Tier 3 GE8 Zhang et al
LRP1B Tier 3 GE8 Zhang et al 7
LRP3 Tier 3 GE8 Zhang et al
LYST Tier 3 GE8 Zhang et al
MAP2K3 Tier 3 GE4 Fan et al
MAP4K4 Tier 3 GE13 Reddy et al FAIL
MARCHF7 Tier 3 GE8 Zhang et al
MARK1 Tier 3 GE13 Reddy et al FAIL
MBL2 Tier 3 GE8 Zhang et al
MCM8 Tier 3 GE4 Fan et al
MED13L Tier 3 GE8 Zhang et al
MIB1 Tier 3 GE8 Zhang et al
MLH1 Tier 3 GE4 Fan et al
MMEL1 Tier 3 GE4 Fan et al
MN1 Tier 3 GE8 Zhang et al
MORC2 Tier 3 GE8 Zhang et al
MPL Tier 3 GE8 Zhang et al
MSH2 Tier 3 GE13 Reddy et al FAIL
MSN Tier 3 GE4 Fan et al
MTMR3 Tier 3 GE8 Zhang et al
MYB Tier 3 GE13 Reddy et al 5 FAIL
MYL7 Tier 3 GE8 Zhang et al
MYO5C Tier 3 GE8 Zhang et al
MYRIP Tier 3 GE8 Zhang et al
NANOG Tier 3 GE58 Chapuy et al FAIL
NCOR1 Tier 3 GE13 Reddy et al FAIL
NDUFS1 Tier 3 GE8 Zhang et al
NELL2 Tier 3 GE8 Zhang et al
NFIB Tier 3 GE8 Zhang et al
NFKB2 Tier 3 GE13 Reddy et al 53 FAIL
NFX1 Tier 3 GE8 Zhang et al
NGFR Tier 3 GE8 Zhang et al
NIPBL Tier 3 GE8 Zhang et al
NLGN2 Tier 3 GE8 Zhang et al
NLRP7 Tier 3 GE8 Zhang et al
NLRP8 Tier 3 GE58 Chapuy et al FAIL
NOTCH3 Tier 3 GE4 Fan et al
NPHP1 Tier 3 GE8 Zhang et al
NPY2R Tier 3 GE8 Zhang et al
NR2F2 Tier 3 GE6 Hubschmann et al FAIL
NRXN2 Tier 3 GE8 Zhang et al 11
NSD1 Tier 3 GE8 Zhang et al
NSD2 Tier 3 GE8 Zhang et al 15
NUP153 Tier 3 GE4 Fan et al
ONECUT1 Tier 3 GE8 Zhang et al
PABPC1 Tier 3 GE4 Fan et al
PADI1 Tier 3 GE8 Zhang et al
PAPPA2 Tier 3 GE8 Zhang et al
PBX1 Tier 3 GE8 Zhang et al
PCCB Tier 3 GE8 Zhang et al
PCDE1C Tier 3 GE8 Zhang et al
PCDH7 Tier 3 GE8 Zhang et al
PCDHB1 Tier 3 GE8 Zhang et al
PCDHB15 Tier 3 GE8 Zhang et al
PCDHB3 Tier 3 GE8 Zhang et al
PCDHB5 Tier 3 GE8 Zhang et al
PCDHGA2 Tier 3 GE8 Zhang et al
PDE1C Tier 3 GE8 Zhang et al
PDE4DIP Tier 3 GE58 Chapuy et al FAIL
PDGFRA Tier 3 GE8 Zhang et al
PDGFRB Tier 3 GE4 Fan et al
PDIA2 Tier 3 GE8 Zhang et al
PDZRN3 Tier 3 GE8 Zhang et al 43
PDZRN4 Tier 3 GE8 Zhang et al
PFN1 Tier 3 GE4 Fan et al
PGR Tier 3 GE4 Fan et al
PHF6 Tier 3 GE13 Reddy et al 57 FAIL
PKD1 Tier 3 GE44 Morin et al FAIL
PLA2G4B Tier 3 GE8 Zhang et al
PLCB4 Tier 3 GE4 Fan et al
PLCG2 Tier 3 GE4 Fan et al 43
PLEKHA7 Tier 3 GE8 Zhang et al
PNLIPRP1 Tier 3 GE8 Zhang et al
PNPT1 Tier 3 GE8 Zhang et al
POGZ Tier 3 GE44 Morin et al FAIL
POLD3 Tier 3 GE4 Fan et al
POLE Tier 3 GE8 Zhang et al
POLQ Tier 3 GE4 Fan et al
PPARGC1A Tier 3 GE8 Zhang et al
PPP2R2B Tier 3 GE4 Fan et al
PPWD1 Tier 3 GE8 Zhang et al
PRDM16 Tier 3 GE8 Zhang et al
PRKCB1 Tier 3 GE8 Zhang et al
PRKCQ Tier 3 GE8 Zhang et al
PROS1 Tier 3 GE8 Zhang et al
PRSS7 Tier 3 GE8 Zhang et al
PTCH1 Tier 3 GE4 Fan et al
PTPN14 Tier 3 GE8 Zhang et al
PTPN23 Tier 3 GE44 Morin et al FAIL
PTPRF Tier 3 GE8 Zhang et al
PTPRK Tier 3 GE13 Reddy et al FAIL
PTPRT Tier 3 GE8 Zhang et al
PXK Tier 3 GE8 Zhang et al
RAB3GAP1 Tier 3 GE8 Zhang et al
RAD9A Tier 3 GE58 Chapuy et al FAIL
RAF1 Tier 3 GE4 Fan et al 38
RAPGEF2 Tier 3 GE8 Zhang et al
RAPGEF3 Tier 3 GE4 Fan et al
RARA Tier 3 GE13 Reddy et al FAIL
RBM15B Tier 3 GE8 Zhang et al
RECQL4 Tier 3 GE4 Fan et al
RELN Tier 3 GE8 Zhang et al 25
RET Tier 3 GE4 Fan et al 11
RFC1 Tier 3 GE8 Zhang et al
RGS1 Tier 3 GE8 Zhang et al 53
RHPN2 Tier 3 GE4 Fan et al
RIF1 Tier 3 GE4 Fan et al
RIMS4 Tier 3 GE4 Fan et al
ROR2 Tier 3 GE8 Zhang et al
RPTOR Tier 3 GE4 Fan et al
RSL1D1 Tier 3 GE8 Zhang et al
RUNDC1 Tier 3 GE8 Zhang et al
RUNX1 Tier 3 GE13 Reddy et al FAIL
RYR1 Tier 3 GE8 Zhang et al
SAPS3 Tier 3 GE8 Zhang et al
SARM1 Tier 3 GE44 Morin et al FAIL
SCYL1 Tier 3 GE8 Zhang et al
SEMA3A Tier 3 GE8 Zhang et al
SEMA3D Tier 3 GE8 Zhang et al
SEMA5A Tier 3 GE8 Zhang et al
SERINC2 Tier 3 GE8 Zhang et al
SH3PXD2B Tier 3 GE8 Zhang et al
SHMT2 Tier 3 GE8 Zhang et al
SIGLEC10 Tier 3 GE8 Zhang et al
SLC16A7 Tier 3 GE8 Zhang et al
SLC16A8 Tier 3 GE4 Fan et al
SLC4A8 Tier 3 GE8 Zhang et al
SLC5A1 Tier 3 GE8 Zhang et al
SLC9A5 Tier 3 GE8 Zhang et al
SMO Tier 3 GE4 Fan et al
SOS2 Tier 3 GE4 Fan et al
SOX6 Tier 3 GE8 Zhang et al
SPEG Tier 3 GE8 Zhang et al
SPTBN1 Tier 3 GE8 Zhang et al
ST8SIA3 Tier 3 GE8 Zhang et al
SULF2 Tier 3 GE8 Zhang et al
SYK Tier 3 GE13 Reddy et al FAIL
TAF1L Tier 3 GE8 Zhang et al
TAF4B Tier 3 GE8 Zhang et al
TECRL Tier 3 GE4 Fan et al
THBS4 Tier 3 GE8 Zhang et al
TIMM50 Tier 3 GE8 Zhang et al
TLN1 Tier 3 GE4 Fan et al
TLN2 Tier 3 GE8 Zhang et al
TLR4 Tier 3 GE4 Fan et al
TMC1 Tier 3 GE8 Zhang et al
TMEM161A Tier 3 GE8 Zhang et al
TMEM16E Tier 3 GE8 Zhang et al
TMEM63A Tier 3 GE8 Zhang et al
TNPO1 Tier 3 GE4 Fan et al
TPR Tier 3 GE4 Fan et al
TPRKB Tier 3 GE8 Zhang et al
TRIM37 Tier 3 GE8 Zhang et al
TRIP11 Tier 3 GE8 Zhang et al 20
TRRAP Tier 3 GE8 Zhang et al 12
TSC2 Tier 3 GE8 Zhang et al
TSHZ2 Tier 3 GE8 Zhang et al
TYRO3 Tier 3 GE4 Fan et al
UBXN11 Tier 3 GE4 Fan et al
UBXN2B Tier 3 GE4 Fan et al
UHRF1BP1L Tier 3 GE8 Zhang et al
UNC13B Tier 3 GE8 Zhang et al
UQCRC1 Tier 3 GE8 Zhang et al
VANGL1 Tier 3 GE4 Fan et al
VPS13A Tier 3 GE8 Zhang et al
WAC Tier 3 GE13 Reddy et al 12 FAIL
WDR65 Tier 3 GE8 Zhang et al
WDR66 Tier 3 GE8 Zhang et al
WDR67 Tier 3 GE8 Zhang et al
WIF1 Tier 3 GE8 Zhang et al
WNK4 Tier 3 GE8 Zhang et al
WT1 Tier 3 GE8 Zhang et al
XDH Tier 3 GE8 Zhang et al
ZBTB7A Tier 3 GE13 Reddy et al 24 FAIL
ZFAT Tier 3 GE13 Reddy et al FAIL
ZIC4 Tier 3 GE8 Zhang et al
ZMYM4 Tier 3 GE4 Fan et al
ZNF354A Tier 3 GE8 Zhang et al
ZNF366 Tier 3 GE8 Zhang et al
ZNF439 Tier 3 GE8 Zhang et al
ZNF474 Tier 3 GE8 Zhang et al
ZNF700 Tier 3 GE8 Zhang et al
ZNF790 Tier 3 GE8 Zhang et al
ZNF814 Tier 3 GE4 Fan et al
ZNF91 Tier 3 GE8 Zhang et al
ZP1 Tier 3 GE8 Zhang et al

References

1.
Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL, Novak AJ, Dogan A, Ansell SM, Link BK, Zou L, Gould J, Saksena G, Stransky N, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Hernández-Lemus E, Schwarz-Cruz y Celis A, Imaz-Rosshandler I, Ojesina AI, Jung J, Pedamallu CS, Lander ES, Habermann TM, Cerhan JR, Shipp MA, Getz G, Golub TR. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3879–3884. PMCID: PMC3309757
2.
Dreval K, Hilton LK, Cruz M, Shaalan H, Ben-Neriah S, Boyle M, Collinge B, Coyle KM, Duns G, Farinha P, Grande BM, Meissner B, Pararajalingam P, Rushton CK, Slack GW, Wong J, Mungall AJ, Marra MA, Connors JM, Steidl C, Scott DW, Morin RD. Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns. Blood. 2023 Aug 10;142(6):561–573. PMCID: PMC10644066
3.
Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, Kim J, Kamburov A, Wood TR, Cader FZ, Ducar MD, Thorner AR, Nag A, Heubeck AT, Buonopane MJ, Redd RA, Bojarczuk K, Lawton LN, Armand P, Rodig SJ, Fromm JR, Getz G, Shipp MA. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Adv. 2019 Dec 10;3(23):4065–4080. PMCID: PMC6963251
4.
Fan Z, Pei R, Sha K, Chen L, Wang T, Lu Y. Comprehensive characterization of driver genes in diffuse large B cell lymphoma. Oncol Lett. 2020 Jul;20(1):382–390. PMCID: PMC7285964
5.
Desch AK, Hartung K, Botzen A, Brobeil A, Rummel M, Kurch L, Georgi T, Jox T, Bielack S, Burdach S, Classen CF, Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW, Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A, Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz R, Kluge R, Mauz-Körholz C, Körholz D, Gattenlöhner S, Bräuninger A. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. Leukemia. 2020 Jan;34(1):151–166.
6.
Hübschmann D, Kleinheinz K, Wagener R, Bernhart SH, López C, Toprak UH, Sungalee S, Ishaque N, Kretzmer H, Kreuz M, Waszak SM, Paramasivam N, Ammerpohl O, Aukema SM, Beekman R, Bergmann AK, Bieg M, Binder H, Borkhardt A, Borst C, Brors B, Bruns P, Carrillo de Santa Pau E, Claviez A, Doose G, Haake A, Karsch D, Haas S, Hansmann ML, Hoell JI, Hovestadt V, Huang B, Hummel M, Jäger-Schmidt C, Kerssemakers JNA, Korbel JO, Kube D, Lawerenz C, Lenze D, Martens JHA, Ott G, Radlwimmer B, Reisinger E, Richter J, Rico D, Rosenstiel P, Rosenwald A, Schillhabel M, Stilgenbauer S, Stadler PF, Martín-Subero JI, Szczepanowski M, Warsow G, Weniger MA, Zapatka M, Valencia A, Stunnenberg HG, Lichter P, Möller P, Loeffler M, Eils R, Klapper W, Hoffmann S, Trümper L, ICGC MMML-Seq consortium, ICGC DE-Mining consortium, BLUEPRINT consortium, Küppers R, Schlesner M, Siebert R. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas. Leukemia. 2021 Jul;35(7):2002–2016. PMCID: PMC8257491
7.
Spina V, Khiabanian H, Messina M, Monti S, Cascione L, Bruscaggin A, Spaccarotella E, Holmes AB, Arcaini L, Lucioni M, Tabbò F, Zairis S, Diop F, Cerri M, Chiaretti S, Marasca R, Ponzoni M, Deaglio S, Ramponi A, Tiacci E, Pasqualucci L, Paulli M, Falini B, Inghirami G, Bertoni F, Foà R, Rabadan R, Gaidano G, Rossi D. The genetics of nodal marginal zone lymphoma. Blood. 2016 Sep 8;128(10):1362–1373. PMCID: PMC5016706
8.
Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C, Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J, Chadburn A, Levy S, Dunson D, Dave SS. Genetic heterogeneity of diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:1398–1403. PMCID: PMC3557051
9.
Barisic D, Chin CR, Meydan C, Teater M, Tsialta I, Mlynarczyk C, Chadburn A, Wang X, Sarkozy M, Xia M, Carson SE, Raggiri S, Debek S, Pelzer B, Durmaz C, Deng Q, Lakra P, Rivas M, Steidl C, Scott DW, Weng AP, Mason CE, Green MR, Melnick A. ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer Cell. 2024 Apr 8;42(4):583–604.e11.
10.
Krysiak K, Gomez F, White BS, Matlock M, Miller CA, Trani L, Fronick CC, Fulton RS, Kreisel F, Cashen AF, Carson KR, Berrien-Elliott MM, Bartlett NL, Griffith M, Griffith OL, Fehniger TA. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood. 2017 Jan 26;129(4):473–483. PMCID: PMC5270390
11.
Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325. PMCID: PMC3674561
12.
Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V, Monti S, Vaisitti T, Arruga F, Famà R, Ciardullo C, Greco M, Cresta S, Piranda D, Holmes A, Fabbri G, Messina M, Rinaldi A, Wang J, Agostinelli C, Piccaluga PP, Lucioni M, Tabbò F, Serra R, Franceschetti S, Deambrogi C, Daniele G, Gattei V, Marasca R, Facchetti F, Arcaini L, Inghirami G, Bertoni F, Pileri SA, Deaglio S, Foà R, Dalla-Favera R, Pasqualucci L, Rabadan R, Gaidano G. The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med. 2012 Aug 27;209(9):1537–1551. PMCID: PMC3428941
13.
Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell. 2017 Oct;171(2):481–494.e15. PMCID: PMC5659841
14.
Camacho E, Hernández L, Hernández S, Tort F, Bellosillo B, Beà S, Bosch F, Montserrat E, Cardesa A, Fernández PL, Campo E. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood. 2002 Jan 1;99(1):238–244.
15.
Beà S, Valdés-Mas R, Navarro A, Salaverria I, Martín-Garcia D, Jares P, Giné E, Pinyol M, Royo C, Nadeu F, Conde L, Juan M, Clot G, Vizán P, Croce LD, Puente DA, López-Guerra M, Moros A, Roue G, Aymerich M, Villamor N, Colomo L, Martínez A, Valera A, Martín-Subero JI, Amador V, Hernández L, Rozman M, Enjuanes A, Forcada P, Muntañola A, Hartmann EM, Calasanz MJ, Rosenwald A, Ott G, Hernández-Rivas JM, Klapper W, Siebert R, Wiestner A, Wilson WH, Colomer D, López-Guillermo A, López-Otín C, Puente XS, Campo E. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. PNAS. 2013;110(45):18250–18255.
16.
Braggio E, Dogan A, Keats JJ, Chng WJ, Huang G, Matthews JM, Maurer MJ, Law ME, Bosler DS, Barrett M, Lossos IS, Witzig TE, Fonseca R. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol. 2012 May;25(5):651–660. PMCID: PMC3341516
17.
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJM, Connors JM, Hirst M, Gascoyne RD, Marra MA. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011 Jul 27;476(7360):298–303. PMCID: PMC3210554
18.
Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV, Dominguez-Sola D, Pasqualucci L, Dalla-Favera R. Combined genetic inactivation of Β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell. 2011 Dec 13;20(6):728–740. PMCID: PMC3660995
19.
Pararajalingam P, Coyle KM, Arthur SE, Thomas N, Alcaide M, Meissner B, Boyle M, Qureshi Q, Grande BM, Rushton C, Slack GW, Mungall AJ, Tam CS, Agarwal R, Dawson SJ, Lenz G, Balasubramanian S, Gascoyne RD, Steidl C, Connors J, Villa D, Audas TE, Marra MA, Johnson NA, Scott DW, Morin RD. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood. 2020 Jul 30;136(5):572–584. PMCID: PMC7440974
20.
Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y, Gaiolla R, Eng K, Brody J, Inghirami G, Carlo-Stella C, Santoro A, Rahal D, Totonchy J, Elemento O, Cesarman E, Roshal M. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 2015 Feb 12;125(7):1061–1072.
21.
Xia M, David L, Teater M, Gutierrez J, Wang X, Meydan C, Lytle A, Slack GW, Scott DW, Morin RD, Onder O, Elenitoba-Johnson KSJ, Zamponi N, Cerchietti L, Lu T, Philippar U, Fontan L, Wu H, Melnick AM. BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL. Cancer Discov. 2022 Aug 5;12(8):1922–1941. PMCID: PMC9357155
22.
Russler-Germain DA, Krysiak K, Ramirez CA, Mosior M, Watkins MP, Gomez F, Skidmore ZL, Trani L, Gao F, Geyer S, Cashen A, Mehta-Shah N, Kahl B, Bartlett N, Alderuccio J, Lossos I, Ondrejka S, Hsi E, Martin P, Leonard J, Griffith M, Griffith O, Fehniger T. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303. Blood Advances. 2023;7:5524–5539.
23.
Tanaka S, Louie DC, Kant JA, Reed JC. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin’s lymphomas. Blood. 1992 Jan 1;79(1):229–237.
24.
Burkhardt B, Michgehl U, Rohde J, Erdmann T, Berning P, Reutter K, Rohde M, Borkhardt A, Burmeister T, Dave S, Tzankov A, Dugas M, Sandmann S, Fend F, Finger J, Mueller S, Gökbuget N, Haferlach T, Kern W, Hartmann W, Klapper W, Oschlies I, Richter J, Kontny U, Lutz M, Maecker-Kolhoff B, Ott G, Rosenwald A, Siebert R, von Stackelberg A, Strahm B, Woessmann W, Zimmermann M, Zapukhlyak M, Grau M, Lenz G. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun. 2022 Jul 6;13(1):3881. PMCID: PMC9259584
25.
Sarkozy C, Hung SS, Chavez EA, Duns G, Takata K, Chong LC, Aoki T, Jiang A, Miyata-Takata T, Telenius A, Slack GW, Molina TJ, Ben-Neriah S, Farinha P, Dartigues P, Damotte D, Mottok A, Salles GA, Casasnovas RO, Savage KJ, Laurent C, Scott DW, Traverse-Glehen A, Steidl C. Mutational landscape of gray zone lymphoma. Blood. 2021 Apr 1;137(13):1765–1776.
26.
Mascle X, Albagli O, Lemercier C. Point mutations in BCL6 DNA-binding domain reveal distinct roles for the six zinc fingers. Biochem Biophys Res Commun. 2003 Jan 10;300(2):391–396.
27.
Baliñas-Gavira C, Rodríguez MI, Andrades Á, Cuadros M, Álvarez-Pérez J, Álvarez-Prado ÁF, Yébenes VG de, Sanchez-Hernandez S, Fernández-Vigo E, Muñoz J, Martín F, Ramiro A, Martinez-Climent J, Medina P. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL. Leukemia. 2020;1–14.
28.
Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA, Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL, He Y, Irvin JD, Jaffe ES, Jones SJM, Kerchan P, Knoetze N, Leal FE, Lichtenberg TM, Ma Y, Martin JP, Martin MR, Mbulaiteye SM, Mullighan CG, Mungall AJ, Namirembe C, Novik K, Noy A, Ogwang MD, Omoding A, Orem J, Reynolds SJ, Rushton CK, Sandlund JT, Schmitz R, Taylor C, Wilson WH, Wright GW, Zhao EY, Marra MA, Morin RD, Staudt LM. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019;133(12):1313–1324. PMCID: PMC6428665
29.
Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, Pucciarini A, Bigerna B, Pacini R, Wells VA, Sportoletti P, Pettirossi V, Mannucci R, Elliott O, Liso A, Ambrosetti A, Pulsoni A, Forconi F, Trentin L, Semenzato G, Inghirami G, Capponi M, Di Raimondo F, Patti C, Arcaini L, Musto P, Pileri S, Haferlach C, Schnittger S, Pizzolo G, Foà R, Farinelli L, Haferlach T, Pasqualucci L, Rabadan R, Falini B. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011 Jun 16;364(24):2305–2315. PMCID: PMC3689585
30.
Wan PTC, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Jones CM, Marshall CJ, Springer CJ, Barford D, Marais R, Cancer Genome Project. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004 Mar 19;116(6):855–867.
31.
Almasmoum HA, Airhihen B, Seedhouse C, Winkler GS. Frequent loss of BTG1 activity and impaired interactions with the Caf1 subunit of the Ccr4-Not deadenylase in non-Hodgkin lymphoma. Leuk Lymphoma. 2021 Feb;62(2):281–290.
32.
Albuquerque MA, Grande BM, Ritch EJ, Pararajalingam P, Jessa S, Krzywinski M, Grewal JK, Shah SP, Boutros PC, Morin RD. Enhancing knowledge discovery from cancer genomics data with Galaxy. Gigascience. 2017 May 1;6(5):1–13. PMCID: PMC5437943
33.
Hu N, Wang F, Sun T, Xu Z, Zhang J, Bernard D, Xu S, Wang S, Kaminski M, Devata S, Phillips T, Malek SN. Follicular Lymphoma-associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation. Clin Cancer Res. 2021 Apr 15;27(8):2301–2313. PMCID: PMC8046715
34.
Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008 Mar;319(5870):1676–1679.
35.
Wu C, de Miranda NF, Chen L, Wasik AM, Mansouri L, Jurczak W, Galazka K, Dlugosz-Danecka M, Machaczka M, Zhang H, Peng R, Morin RD, Rosenquist R, Sander B, Pan-Hammarström Q. Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations. Oncotarget. 2016 Jun 21;7(25):38180–38190. PMCID: PMC5122381
36.
Yan Q, Huang Y, Watkins AJ, Kocialkowski S, Zeng N, Hamoudi RA, Isaacson PG, de Leval L, Wotherspoon A, Du MQ. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. Haematologica. 2012 Apr;97(4):595–598. PMCID: PMC3347666
37.
Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012 Oct 4;490(7418):116–120. PMCID: PMC3609867
38.
Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A. Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica. 2017 Oct;102(10):1758–1766. PMCID: PMC5622860
39.
Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B, Rosolowski M, Ammerpohl O, Wagener R, Bernhart SH, Lenze D, Szczepanowski M, Paulsen M, Lipinski S, Russell RB, Adam-Klages S, Apic G, Claviez A, Hasenclever D, Hovestadt V, Hornig N, Korbel JO, Kube D, Langenberger D, Lawerenz C, Lisfeld J, Meyer K, Picelli S, Pischimarov J, Radlwimmer B, Rausch T, Rohde M, Schilhabel M, Scholtysik R, Spang R, Trautmann H, Zenz T, Borkhardt A, Drexler HG, Möller P, MacLeod RAF, Pott C, Schreiber S, Trümper L, Loeffler M, Stadler PF, Lichter P, Eils R, Küppers R, Hummel M, Klapper W, Rosenstiel P, Rosenwald A, Brors B, Siebert R, ICGC MMML-Seq Project. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet. 2012 Dec;44(12):1316–1320.
40.
Schneider M, Schneider S, Zühlke-Jenisch R, Klapper W, Sundström C, Hartmann S, Hansmann ML, Siebert R, Küppers R, Giefing M. Alterations of the CD58 gene in classical Hodgkin lymphoma. Genes Chromosomes Cancer. 2015 Oct;54(10):638–645.
41.
Nie M, Ren W, Ye X, Berglund M, Wang X, Fjordén K, Du L, Giannoula Y, Lei D, Su W, Li W, Liu D, Linderoth J, Jiang C, Bao H, Jiang W, Huang H, Hou Y, Zhu S, Enblad G, Jerkeman M, Wu K, Zhang H, Amini RM, Li ZM, Pan-Hammarström Q. The dual role of CD70 in B-cell lymphomagenesis. Clin Transl Med. 2022 Dec;12(12):e1118. PMCID: PMC9722974
42.
Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, Jaffe ES, Wilson WH, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pierce SK, Staudt LM. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 2010 Jan;463(7277):88–92. PMCID: PMC2845535
43.
Panea R, Love C, Shingleton JR, Reddy A, Bailey J, Moormann A, Otieno J, Ong’echa J, Oduor C, Schroêder K, Masalu N, Chao N, Agajanian M, Major M, Fedoriw Y, Richards K, Rymkiewicz G, Miles R, Alobeid B, Bhagat G, Flowers C, Ondrejka S, Hsi E, Choi W, Au-Yeung R, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig M, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus B, Seshadri V, Kim S, Gascoyne R, Levy S, Mukhopadhyay M, Dunson D, Dave S. The whole genome landscape of Burkitt lymphoma subtypes. Blood. 2019;
44.
Morin RD, Mungall K, Pleasance E, Mungall AJ, Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC, Mendez-Lago M, Trinh DL, Bolger-Munro M, Taylor G, Hadj Khodabakhshi A, Ben-Neriah S, Pon J, Meissner B, Woolcock B, Farnoud N, Rogic S, Lim EL, Johnson NA, Shah S, Jones S, Steidl C, Holt R, Birol I, Moore R, Connors JM, Gascoyne RD, Marra MA. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood. 2013 Aug 15;122(7):1256–1265. PMCID: PMC3744992
45.
Duns G, Viganò E, Ennishi D, Sarkozy C, Hung SS, Chavez E, Takata K, Rushton C, Jiang A, Ben-Neriah S, Woolcock BW, Slack GW, Hsi ED, Craig JW, Hilton LK, Shah SP, Farinha P, Mottok A, Gascoyne RD, Morin RD, Savage KJ, Scott DW, Steidl C. Characterization of DLBCL with a PMBL gene expression signature. Blood. 2021 Jul 15;138(2):136–148.
46.
Kannengiesser C, Brookes S, del Arroyo AG, Pham D, Bombled J, Barrois M, Mauffret O, Avril MFM, Chompret A, Lenoir GM, Sarasin A, French Hereditary Melanoma Study Group, Peters G, Bressac-de Paillerets B. Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients. Hum Mutat. 2009 Apr;30(4):564–574.
47.
Mottok A, Woolcock B, Chan FC, Tong KM, Chong L, Farinha P, Telenius A, Chavez E, Ramchandani S, Drake M, Boyle M, Ben-Neriah S, Scott DW, Rimsza LM, Siebert R, Gascoyne RD, Steidl C. Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression. Cell Rep. 2015 Nov 17;13(7):1418–1431.
48.
Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, Dalla-Favera R. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011 Mar 10;471(7337):189–195. PMCID: PMC3271441
49.
Parry M, Rose-Zerilli MJJ, Gibson J, Ennis S, Walewska R, Forster J, Parker H, Davis Z, Gardiner A, Collins A, Oscier DG, Strefford JC. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. PLoS One. 2013;8(12):e83244. PMCID: PMC3862727
50.
Khodabakhshi AH, Morin RD, Fejes AP, Mungall AJ, Mungall KL, Bolger-Munro M, Johnson NA, Connors JM, Gascoyne RD, Marra MA, Birol I, Jones SJM. Recurrent targets of aberrant somatic hypermutation in lymphoma. Oncotarget. 2012;3(11):1308–1319. PMCID: PMC3717795
51.
Zmajkovicova K, Pawar S, Maier-Munsa S, Maierhofer B, Wiest I, Skerlj R, Taveras AG, Badarau A. Genotype-phenotype correlations in WHIM syndrome: A systematic characterization of CXCR4WHIM variants. Genes Immun. 2022 Sep;23(6):196–204. PMCID: PMC9519442
52.
Gong C, Krupka JA, Gao J, Grigoropoulos NF, Giotopoulos G, Asby R, Screen M, Usheva Z, Cucco F, Barrans S, Painter D, Zaini NBM, Haupl B, Bornelöv S, Ruiz De Los Mozos I, Meng W, Zhou P, Blain AE, Forde S, Matthews J, Khim Tan MG, Burke GAA, Sze SK, Beer P, Burton C, Campbell P, Rand V, Turner SD, Ule J, Roman E, Tooze R, Oellerich T, Huntly BJ, Turner M, Du MQ, Samarajiwa SA, Hodson DJ. Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis. Molecular Cell. 2021;
53.
Mottok A, Hung SS, Chavez EA, Woolcock B, Telenius A, Chong LC, Meissner B, Nakamura H, Rushton C, Viganò E, Sarkozy C, Gascoyne RD, Connors JM, Ben-Neriah S, Mungall A, Marra MA, Siebert R, Scott DW, Savage KJ, Steidl C. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. Blood. 2019 Sep 5;134(10):802–813.
54.
Gomez F, Fisk B, McMichael JF, Mosior M, Foltz JA, Skidmore ZL, Duncavage EJ, Miller CA, Abel H, Li YS, Russler-Germain DA, Krysiak K, Watkins MP, Ramirez CA, Schmidt A, Martins Rodrigues F, Trani L, Khanna A, Wagner JA, Fulton RS, Fronick CC, O’Laughlin MD, Schappe T, Cashen AF, Mehta-Shah N, Kahl BS, Walker J, Bartlett NL, Griffith M, Fehniger TA, Griffith OL. Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. Cancer Res Commun. 2023 Nov 15;3(11):2312–2330. PMCID: PMC10648575
55.
Bohle V, Döring C, Hansmann M-L, Küppers R. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma. Leukemia. 2013 Mar;27(3):671–679.
56.
Ramírez-Komo JA, Delaney MA, Straign D, Lukin K, Tsang M, Iritani BM, Hagman J. Spontaneous loss of B lineage transcription factors leads to pre-B leukemia in Ebf1+/-Bcl-xLTg mice. Oncogenesis. 2017 Jul 10;6(7):e355. PMCID: PMC5541707
57.
Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, Barta S, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Chadburn A, Cruz M, Dittmer DP, Dyer MA, Farinha P, Gastier-Foster JM, Gerrie AS, Grande BM, Greiner T, Griner NB, Gross TG, Harris NL, Irvin JD, Jaffe ES, Henry D, Huppi R, Leal FE, Lee MS, Martin JP, Martin MR, Mbulaiteye SM, Mitsuyasu R, Morris V, Mullighan CG, Mungall AJ, Mungall K, Mutyaba I, Nokta M, Namirembe C, Noy A, Ogwang MD, Omoding A, Orem J, Ott G, Petrello H, Pittaluga S, Phelan JD, Ramos JC, Ratner L, Reynolds SJ, Rubinstein PG, Sissolak G, Slack G, Soudi S, Swerdlow SH, Traverse-Glehen A, Wilson WH, Wong J, Yarchoan R, ZenKlusen JC, Marra MA, Staudt LM, Scott DW, Morin RD. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023 Feb 23;141(8):904–916. PMCID: PMC10023728
58.
Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, Staiger AM, Wala JA, Ducar MD, Leshchiner I, Rheinbay E, Taylor-Weiner A, Coughlin CA, Hess JM, Pedamallu CS, Livitz D, Rosebrock D, Rosenberg M, Tracy AA, Horn H, van Hummelen P, Feldman AL, Link BK, Novak AJ, Cerhan JR, Habermann TM, Siebert R, Rosenwald A, Thorner AR, Meyerson ML, Golub TR, Beroukhim R, Wulf GG, Ott G, Rodig SJ, Monti S, Neuberg DS, Loeffler M, Pfreundschuh M, Trümper L, Getz G, Shipp MA. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018 May;24(5):679–690. PMCID: PMC6613387
59.
Wang Q, Dong S, Yao H, Wen L, Qiu H, Qin L, Ma L, Chen S. ETV6 mutation in a cohort of 970 patients with hematologic malignancies. Haematologica. 2014 Oct;99(10):e176–178. PMCID: PMC4181263
60.
Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, Yap D, Humphries RK, Griffith OL, Shah S, Zhu H, Kimbara M, Shashkin P, Charlot JF, Tcherpakov M, Corbett R, Tam A, Varhol R, Smailus D, Moksa M, Zhao Y, Delaney A, Qian H, Birol I, Schein J, Moore R, Holt R, Horsman DE, Connors JM, Jones S, Aparicio S, Hirst M, Gascoyne RD, Marra MA. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010 Feb;42(2):181–185. PMCID: PMC2850970
61.
Sneeringer CJ, Scott MP, Kuntz KW, Knutson SK, Pollock RM, Richon VM, Copeland RA. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):20980–20985. PMCID: PMC3000297
62.
Scholl V, Stefanoff CG, Hassan R, Spector N, Renault IZ. Mutations within the 5’ region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma. Leuk Lymphoma. 2007 May;48(5):957–963.
63.
Wang L, Yang JK, Kabaleeswaran V, Rice AJ, Cruz AC, Park AY, Yin Q, Damko E, Jang SB, Raunser S, Robinson CV, Siegel RM, Walz T, Wu H. The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat Struct Mol Biol. 2010 Nov;17(11):1324–1329. PMCID: PMC2988912
64.
Arthur SE, Jiang A, Grande BM, Alcaide M, Cojocaru R, Rushton CK, Mottok A, Hilton LK, Lat PK, Zhao EY, Culibrk L, Ennishi D, Jessa S, Chong L, Thomas N, Pararajalingam P, Meissner B, Boyle M, Davidson J, Bushell KR, Lai D, Farinha P, Slack GW, Morin GB, Shah S, Sen D, Jones SJM, Mungall AJ, Gascoyne RD, Audas TE, Unrau P, Marra MA, Connors JM, Steidl C, Scott DW, Morin RD. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat Commun. 2018 Oct 1;9(1):4001. PMCID: PMC6167379
65.
Duan S, Cermak L, Pagan JK, Rossi M, Martinengo C, di Celle PF, Chapuy B, Shipp M, Chiarle R, Pagano M. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas. Nature. 2011 Nov;
66.
Saffie R, Zhou N, Rolland D, Önder Ö, Basrur V, Campbell S, Wellen KE, Elenitoba-Johnson KSJ, Capell BC, Busino L. FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells. Cancer Res. 2020 Jun 15;80(12):2498–2511. PMCID: PMC7417195
67.
Trinh DL, Scott DW, Morin RD, Mendez-Lago M, An J, Jones SJM, Mungall AJ, Zhao Y, Schein J, Steidl C, Connors JM, Gascoyne RD, Marra MA. Analysis of FOXO1 mutations in diffuse large B-cell lymphoma. Blood. 2013;121(18):3666–3674. PMCID: PMC3643765
68.
Muppidi J, Schmitz R, Green JA, Green JA, Xiao W, Larsen AB, Braun S, An J, Xu Y, Rosenwald A, Ott G, Gascoyne R, Rimsza L, Campo E, Jaffe E, Delabie J, Smeland E, Braziel R, Tubbs R, Cook J, Weisenburger D, Chan W, Vaidehi N, Staudt L, Cyster J. Loss of signaling via Gα13 in germinal center B cell-derived lymphoma. Nature. 2014;516:254–258.
69.
Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Rabadan R, Dalla-Favera R. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet. 2011 Jul 31;43(9):830–837. PMCID: PMC3297422
70.
Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, Hodson DJ, Xiao W, Yu X, Yang Y, Zhao H, Xu W, Liu X, Zhou B, Du W, Chan WC, Jaffe ES, Gascoyne RD, Connors JM, Campo E, Lopez-Guillermo A, Rosenwald A, Ott G, Delabie J, Rimsza LM, Tay Kuang Wei K, Zelenetz AD, Leonard JP, Bartlett NL, Tran B, Shetty J, Zhao Y, Soppet DR, Pittaluga S, Wilson WH, Staudt LM. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. N Engl J Med. 2018 Apr 12;378(15):1396–1407. PMCID: PMC6010183
71.
Fangazio M, Ladewig E, Gomez K, Garcia-Ibanez L, Kumar R, Teruya-Feldstein J, Rossi D, Filip I, Pan-Hammarström Q, Inghirami G, Boldorini R, Ott G, Staiger AM, Chapuy B, Gaidano G, Bhagat G, Basso K, Rabadan R, Pasqualucci L, Dalla-Favera R. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A. 2021 Jun 1;118(22):e2104504118. PMCID: PMC8179151
72.
Lazarian G, Yin S, Ten Hacken E, Sewastianik T, Uduman M, Font-Tello A, Gohil SH, Li S, Kim E, Joyal H, Billington L, Witten E, Zheng M, Huang T, Severgnini M, Lefebvre V, Rassenti LZ, Gutierrez C, Georgopoulos K, Ott CJ, Wang L, Kipps TJ, Burger JA, Livak KJ, Neuberg DS, Baran-Marszak F, Cymbalista F, Carrasco RD, Wu CJ. A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation. Cancer Cell. 2021 Mar 8;39(3):380–393.e8. PMCID: PMC8034546
73.
Viganò E, Gunawardana J, Mottok A, Van Tol T, Mak K, Chan FC, Chong L, Chavez E, Woolcock B, Takata K, Twa D, Shulha HP, Telenius A, Kutovaya O, Hung SS, Healy S, Ben-Neriah S, Leroy K, Gaulard P, Diepstra A, Kridel R, Savage KJ, Rimsza L, Gascoyne R, Steidl C. Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation. Blood. 2018 May 3;131(18):2036–2046.
74.
Qiu Z, Khalife J, Ethiraj P, Jaafar C, Lin AP, Holder KN, Ritter JP, Chiou L, Huelgas-Morales G, Aslam S, Zhang Z, Liu Z, Arya S, Gupta YK, Dahia PLM, Aguiar RCT. IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes. Sci Adv. 2024 Jul 12;10(28):eadk2091. PMCID: PMC11244530
75.
Tiacci E, Ladewig E, Schiavoni G, Penson A, Fortini E, Pettirossi V, Wang Y, Rosseto A, Venanzi A, Vlasevska S, Pacini R, Piattoni S, Tabarrini A, Pucciarini A, Bigerna B, Santi A, Gianni AM, Viviani S, Cabras A, Ascani S, Crescenzi B, Mecucci C, Pasqualucci L, Rabadan R, Falini B. Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. Blood. 2018 May 31;131(22):2454–2465. PMCID: PMC6634958
76.
Choi J, Phelan JD, Wright GW, Häupl B, Huang DW, Shaffer AL, Young RM, Wang Z, Zhao H, Yu X, Oellerich T, Staudt LM. Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14. Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6092–6102. PMCID: PMC7084139
77.
Choi J, Lee K, Ingvarsdottir K, Bonasio R, Saraf A, Florens L, Washburn MP, Tadros S, Green MR, Busino L. Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor Roquin2. Nat Cell Biol. 2018 May;20(5):586–596. PMCID: PMC5926793
78.
Ganapathi KA, Jobanputra V, Iwamoto F, Jain P, Chen J, Cascione L, Nahum O, Levy B, Xie Y, Khattar P, Hoehn D, Bertoni F, Murty VV, Pittaluga S, Jaffe ES, Alobeid B, Mansukhani MM, Bhagat G. The genetic landscape of dural marginal zone lymphomas. Oncotarget. Impact Journals; 2016 May 27;7(28):43052–43061.
79.
Zhang J, Jima D, Moffitt AB, Liu Q, Czader M, Hsi ED, Fedoriw Y, Dunphy CH, Richards KL, Gill JI, Sun Z, Love C, Scotland P, Lock E, Levy S, Hsu DS, Dunson D, Dave SS. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. Blood. 2014 May 8;123(19):2988–2996.
80.
Zhou P, Blain AE, Newman AM, Zaka M, Chagaluka G, Adlar FR, Offor UT, Broadbent C, Chaytor L, Whitehead A, Hall A, O’Connor H, Van Noorden S, Lampert I, Bailey S, Molyneux E, Bacon CM, Bomken S, Rand V. Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif. Blood Adv. 2019 Jul 23;3(14):2118–2127. PMCID: PMC6650741
81.
Zhang J, Dominguez-Sola D, Hussein S, Lee JE, Holmes AB, Bansal M, Vlasevska S, Mo T, Tang H, Basso K, Ge K, Dalla-Favera R, Pasqualucci L. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat Med. 2015 Oct;21(10):1190–1198. PMCID: PMC5145002
82.
Scheffzek K, Ahmadian MR, Kabsch W, Wiesmüller L, Lautwein A, Schmitz F, Wittinghofer A. The Ras-RasGAP complex: Structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science. 1997 Jul 18;277(5324):333–338.
83.
Pon JR, Wong J, Saberi S, Alder O, Moksa M, Grace Cheng S-W, Morin GB, Hoodless PA, Hirst M, Marra MA. MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation. Nature Communications [Internet]. 2015 Aug 6 [cited 2019 Dec 21];6(1):1–15. Available from: https://www.nature.com/articles/ncomms8953
84.
De Paoli L, Cerri M, Monti S, Rasi S, Spina V, Bruscaggin A, Greco M, Ciardullo C, Famà R, Cresta S, Maffei R, Ladetto M, Martini M, Laurenti L, Forconi F, Marasca R, Larocca LM, Bertoni F, Gaidano G, Rossi D. MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia. Leuk Lymphoma. 2013 May;54(5):1087–1090.
85.
Kwanhian W, Lenze D, Alles J, Motsch N, Barth S, Döll C, Imig J, Hummel M, Tinguely M, Trivedi P, Lulitanond V, Meister G, Renner C, Grässer FA. MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Med. 2012 Oct;1(2):141–155. PMCID: PMC3544448
86.
Trissal MC, Wong TN, Yao JC, Ramaswamy R, Kuo I, Baty J, Sun Y, Jih G, Parikh N, Berrien-Elliott MM, Fehniger TA, Ley TJ, Maillard I, Reddy PR, Link DC. MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis. Cancer Res. 2018 Jul 1;78(13):3510–3521. PMCID: PMC6030481
87.
Rushton CK, Arthur SE, Alcaide M, Cheung M, Jiang A, Coyle KM, Cleary KLS, Thomas N, Hilton LK, Michaud N, Daigle S, Davidson J, Bushell K, Yu S, Rys RN, Jain M, Shepherd L, Marra MA, Kuruvilla J, Crump M, Mann K, Assouline S, Connors JM, Steidl C, Cragg MS, Scott DW, Johnson NA, Morin RD. Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma. Blood Adv. 2020 Jul 14;4(13):2886–2898. PMCID: PMC7362366
88.
Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, Jordan A, Beck AH, Sabatini DM. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov. 2014 May;4(5):554–563. PMCID: PMC4012430
89.
Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Küppers R, Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001 Jul 19;412(6844):341–346.
90.
Freie B, Carroll PA, Varnum-Finney BJ, Ramsey EL, Ramani V, Bernstein I, Eisenman RN. A germline point mutation in the MYC-FBW7 phosphodegron initiates hematopoietic malignancies. Genes Dev. 2024 Apr 17;38(5-6):253–272. PMCID: PMC11065175
91.
Johnston JM, Carroll WL. C-myc hypermutation in Burkitt’s lymphoma. Leuk Lymphoma. 1992 Dec;8(6):431–439.
92.
Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Staudt LM. Oncogenically active MYD88 mutations in human lymphoma. Nature. 2011 Feb 3;470(7332):115–119. PMCID: PMC5024568
93.
Thomas RK, Wickenhauser C, Tawadros S, Diehl V, Küppers R, Wolf J, Schmitz R. Mutational analysis of the IkappaBalpha gene in activated B cell-like diffuse large B-cell lymphoma. Br J Haematol. 2004 Jul;126(1):50–54.
94.
Jungnickel B, Staratschek-Jox A, Bräuninger A, Spieker T, Wolf J, Diehl V, Hansmann ML, Rajewsky K, Küppers R. Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin’s lymphoma. J Exp Med. 2000 Jan 17;191(2):395–402. PMCID: PMC2195754
95.
Morin RD, Assouline S, Alcaide M, Mohajeri A, Johnston RL, Chong L, Grewal J, Yu S, Fornika D, Bushell K, Nielsen TH, Petrogiannis-Haliotis T, Crump M, Tosikyan A, Grande BM, MacDonald D, Rousseau C, Bayat M, Sesques P, Froment R, Albuquerque M, Monczak Y, Oros KK, Greenwood C, Riazalhosseini Y, Arseneault M, Camlioglu E, Constantin A, Pan-Hammarstrom Q, Peng R, Mann KK, Johnson NA. Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. Clin Cancer Res. 2016 May 1;22(9):2290–2300.
96.
Mansouri L, Sutton LA, Ljungström V, Bondza S, Arngården L, Bhoi S, Larsson J, Cortese D, Kalushkova A, Plevova K, Young E, Gunnarsson R, Falk-Sörqvist E, Lönn P, Muggen AF, Yan XJ, Sander B, Enblad G, Smedby KE, Juliusson G, Belessi C, Rung J, Chiorazzi N, Strefford JC, Langerak AW, Pospisilova S, Davi F, Hellström M, Jernberg-Wiklund H, Ghia P, Söderberg O, Stamatopoulos K, Nilsson M, Rosenquist R. Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia. J Exp Med. 2015 Jun 1;212(6):833–843. PMCID: PMC4451125
97.
Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V, Schneider M, Yoshida K, Skaftason A, Pandzic T, Gonzalez B, Tasidou A, Waldhueter N, Rivas-Delgado A, Angelopoulou M, Ziepert M, Arends CM, Couronné L, Lenze D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J, Dörken B, Drexler HG, Roos-Weil D, Schmitt CA, Munch-Petersen HD, Zenz T, Hansmann ML, Strefford JC, Enblad G, Bernard OA, Ralfkiaer E, Erlanson M, Korkolopoulou P, Hultdin M, Papadaki T, Grønbæk K, Lopez-Guillermo A, Ogawa S, Küppers R, Stamatopoulos K, Stavroyianni N, Kanellis G, Rosenwald A, Campo E, Amini RM, Ott G, Vassilakopoulos TP, Hummel M, Rosenquist R, Damm F. Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. Blood. 2016 Dec 8;128(23):2666–2670.
98.
Ryan RJH, Petrovic J, Rausch DM, Zhou Y, Lareau CA, Kluk MJ, Christie AL, Lee WY, Tarjan DR, Guo B, Donohue LKH, Gillespie SM, Nardi V, Hochberg EP, Blacklow SC, Weinstock DM, Faryabi RB, Bernstein BE, Aster JC, Pear WS. A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas. Cell Rep. 2017 Oct 17;21(3):784–797. PMCID: PMC5687286
99.
Lee SY, Kumano K, Nakazaki K, Sanada M, Matsumoto A, Yamamoto G, Nannya Y, Suzuki R, Ota S, Ota Y, Izutsu K, Sakata-Yanagimoto M, Hangaishi A, Yagita H, Fukayama M, Seto M, Kurokawa M, Ogawa S, Chiba S. Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma. Cancer Sci. 2009 May;100(5):920–926.
100.
Kuo HP, Ezell SA, Hsieh S, Schweighofer KJ, Cheung LW, Wu S, Apatira M, Sirisawad M, Eckert K, Liang Y, Hsu J, Chen CT, Beaupre D, Chang BY. The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma. Am J Cancer Res. 2016;6(11):2489–2501. PMCID: PMC5126268
101.
González-Rincón J, Méndez M, Gómez S, García JF, Martín P, Bellas C, Pedrosa L, Rodríguez-Pinilla SM, Camacho FI, Quero C, Pérez-Callejo D, Rueda A, Llanos M, Gómez-Codina J, Piris MA, Montes-Moreno S, Bárcena C, Rodríguez-Abreu D, Menárguez J, de la Cruz-Merino L, Monsalvo S, Parejo C, Royuela A, Kwee I, Cascione L, Arribas A, Bertoni F, Mollejo M, Provencio M, Sánchez-Beato M. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma. PLoS One. 2019;14(2):e0212813. PMCID: PMC6388933
102.
Hodson DJ, Shaffer AL, Xiao W, Wright GW, Schmitz R, Phelan JD, Yang Y, Webster DE, Rui L, Kohlhammer H, Nakagawa M, Waldmann TA, Staudt LM. Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2. Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2039–2046. PMCID: PMC4833274
103.
Pasqualucci L, Compagno M, Houldsworth J, Monti S, Grunn A, Nandula SV, Aster JC, Murty VV, Shipp MA, Dalla-Favera R. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med. 2006 Feb;203(2):311–317.
104.
Pfeifer M, Grau M, Lenze D, Wenzel SS, Wolf A, Wollert-Wulf B, Dietze K, Nogai H, Storek B, Madle H, Dörken B, Janz M, Dirnhofer S, Lenz P, Hummel M, Tzankov A, Lenz G. PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12420–12425. PMCID: PMC3725065
105.
Demosthenous C, Han JJ, Hu G, Stenson M, Gupta M. Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma. Oncotarget. 2015 Dec 29;6(42):44703–44713. PMCID: PMC4792586
106.
Pinyol M, Bea S, Plà L, Ribrag V, Bosq J, Rosenwald A, Campo E, Jares P. Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis. Blood. 2007 Jun 15;109(12):5422–5429.
107.
Weber J, de la Rosa J, Grove CS, Schick M, Rad L, Baranov O, Strong A, Pfaus A, Friedrich MJ, Engleitner T, Lersch R, Öllinger R, Grau M, Menendez IG, Martella M, Kohlhofer U, Banerjee R, Turchaninova MA, Scherger A, Hoffman GJ, Hess J, Kuhn LB, Ammon T, Kim J, Schneider G, Unger K, Zimber-Strobl U, Heikenwälder M, Schmidt-Supprian M, Yang F, Saur D, Liu P, Steiger K, Chudakov DM, Lenz G, Quintanilla-Martinez L, Keller U, Vassiliou GS, Cadiñanos J, Bradley A, Rad R. PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice. Nat Commun. 2019 Mar 29;10(1):1415. PMCID: PMC6440946
108.
O’Hayre M, Inoue A, Kufareva I, Wang Z, Mikelis CM, Drummond RA, Avino S, Finkel K, Kalim KW, DiPasquale G, Guo F, Aoki J, Zheng Y, Lionakis MS, Molinolo AA, Gutkind JS. Inactivating mutations in GNA13 and RHOA in Burkitt’s lymphoma and diffuse large B-cell lymphoma: A tumor suppressor function for the Gα13/RhoA axis in B cells. Oncogene. 2016 Jul 21;35(29):3771–3780. PMCID: PMC4885800
109.
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF, Richter J, Bernhart SH, Efeyan A, Iqbal S, Matthews J, Clear A, Guerra-Assunção JA, Bödör C, Quentmeier H, Mansbridge C, Johnson P, Davies A, Strefford JC, Packham G, Barrans S, Jack A, Du MQ, Calaminici M, Lister TA, Auer R, Montoto S, Gribben JG, Siebert R, Chelala C, Zoncu R, Sabatini DM, Fitzgibbon J. Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. Nat Genet. 2016 Feb;48(2):183–188. PMCID: PMC4731318
110.
Cazzola M, Rossi M, Malcovati L, Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative. Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms. Blood. 2013 Jan 10;121(2):260–269. PMCID: PMC3790951
111.
Gao J, Sidiropoulou E, Walker I, Krupka JA, Mizielinski K, Usheva Z, Samarajiwa SA, Hodson DJ. SGK1 mutations in DLBCL generate hyperstable protein neoisoforms that promote AKT independence. Blood. 2021 Sep 16;138(11):959–964. PMCID: PMC8701626
112.
Fernando TM, Piskol R, Bainer R, Sokol ES, Trabucco SE, Zhang Q, Trinh H, Maund S, Kschonsak M, Chaudhuri S, Modrusan Z, Januario T, Yauch RL. Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients. Nat Commun. 2020 Nov 3;11(1):5551. PMCID: PMC7609548
113.
Nadeu F, Martín-García D, Clot G, Díaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggrós M, Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A, Ribera‐Cortada I, Siebert R, Colomer D, Torrents D, Giné E, López-Guillermo A, Küppers R, Martín-Subero J, Puente X, Beà S, Campo E. Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes. Blood. 2020;
114.
Melzner I, Bucur AJ, Brüderlein S, Dorsch K, Hasel C, Barth TFE, Leithäuser F, Möller P. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood. 2005 Mar 15;105(6):2535–2542.
115.
Weniger MA, Melzner I, Menz CK, Wegener S, Bucur AJ, Dorsch K, Mattfeldt T, Barth TFE, Möller P. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene. 2006 Apr 27;25(18):2679–2684.
116.
Hu G, Witzig TE, Gupta M. A novel missense (M206K) STAT3 mutation in diffuse large B cell lymphoma deregulates STAT3 signaling. PLoS One. 2013;8(7):e67851. PMCID: PMC3701620
117.
Yildiz M, Li H, Bernard D, Amin NA, Ouillette P, Jones S, Saiya-Cork K, Parkin B, Jacobi K, Shedden K, Wang S, Chang AE, Kaminski MS, Malek SN. Activating STAT6 mutations in follicular lymphoma. Blood. 2015 Jan 22;125(4):668–679. PMCID: PMC4729538
118.
Mentz M, Keay W, Strobl CD, Antoniolli M, Adolph L, Heide M, Lechner A, Haebe S, Osterode E, Kridel R, Ziegenhain C, Wange LE, Hildebrand JA, Shree T, Silkenstedt E, Staiger AM, Ott G, Horn H, Szczepanowski M, Richter J, Levy R, Rosenwald A, Enard W, Zimber-Strobl U, von Bergwelt-Baildon M, Hiddemann W, Klapper W, Schmidt-Supprian M, Rudelius M, Bararia D, Passerini V, Weigert O. PARP14 is a novel target in STAT6 mutant follicular lymphoma. Leukemia. 2022 Sep;36(9):2281–2292. PMCID: PMC9417990
119.
Ritz O, Guiter C, Castellano F, Dorsch K, Melzner J, Jais JP, Dubois G, Gaulard P, Möller P, Leroy K. Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma. Blood. 2009 Aug 6;114(6):1236–1242. PMCID: PMC2824656
120.
Venturutti L, Teater M, Zhai A, Chadburn A, Babiker L, Kim D, Béguelin W, Lee TC, Kim Y, Chin CR, Yewdell WT, Raught B, Phillip JM, Jiang Y, Staudt LM, Green MR, Chaudhuri J, Elemento O, Farinha P, Weng AP, Nissen MD, Steidl C, Morin RD, Scott DW, Privé GG, Melnick AM. TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate. Cell. 2020 Jul 23;182(2):297–316.e27. PMCID: PMC7384961
121.
Asmar F, Punj V, Christensen J, Pedersen MT, Pedersen A, Nielsen AB, Hother C, Ralfkiaer U, Brown P, Ralfkiaer E, Helin K, Grønbæk K. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica. 2013 Dec;98(12):1912–1920. PMCID: PMC3856967
122.
Ennishi D, Healy S, Bashashati A, Saberi S, Hother C, Mottok A, Chan FC, Chong L, Abraham L, Kridel R, Boyle M, Meissner B, Aoki T, Takata K, Woolcock BW, Viganò E, Gold M, Molday LL, Molday RS, Telenius A, Li MY, Wretham N, Dos Santos N, Wong M, Viller NN, Uger RA, Duns G, Baticados A, Madero A, Bristow BN, Farinha P, Slack GW, Ben-Neriah S, Lai D, Zhang AW, Salehi S, Shulha HP, Chiu DS, Mostafavi S, Gerrie AS, Huang DW, Rushton C, Villa D, Sehn LH, Savage KJ, Mungall AJ, Weng AP, Bally MB, Morin RD, Cohen Freue GV, Staudt LM, Connors JM, Marra MA, Shah SP, Gascoyne RD, Scott DW, Steidl C. TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. Nat Med. 2020 Apr;26(4):577–588. PMCID: PMC8480332
123.
Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q, Bertoni F, Ponzoni M, Scandurra M, Califano A, Bhagat G, Chadburn A, Dalla-Favera R, Pasqualucci L. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature. 2009 Jun 4;459(7247):717–721. PMCID: PMC2973325
124.
Rossi D, Deaglio S, Dominguez-Sola D, Rasi S, Vaisitti T, Agostinelli C, Spina V, Bruscaggin A, Monti S, Cerri M, Cresta S, Fangazio M, Arcaini L, Lucioni M, Marasca R, Thieblemont C, Capello D, Facchetti F, Kwee I, Pileri SA, Foà R, Bertoni F, Dalla-Favera R, Pasqualucci L, Gaidano G. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma. Blood. 2011 Nov 3;118(18):4930–4934.
125.
Schmitz R, Hansmann ML, Bohle V, Martin-Subero JI, Hartmann S, Mechtersheimer G, Klapper W, Vater I, Giefing M, Gesk S, Stanelle J, Siebert R, Küppers R. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med. 2009 May 11;206(5):981–989. PMCID: PMC2715030
126.
Cheung KJJ, Johnson NA, Affleck JG, Severson T, Steidl C, Ben-Neriah S, Schein J, Morin RD, Moore R, Shah SP, Qian H, Paul JE, Telenius A, Relander T, Lam W, Savage K, Connors JM, Brown C, Marra MA, Gascoyne RD, Horsman DE. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res. 2010 Nov 15;70(22):9166–9174.
127.
Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, Ishioka C. Understanding the function-structure and function-mutation relationships of P53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424–8429. PMCID: PMC166245
128.
Wilda M, Bruch J, Harder L, Rawer D, Reiter A, Borkhardt A, Woessmann W. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt’s lymphoma in children. Leukemia. 2004 Mar;18(3):584–588.
129.
Mareschal S, Dubois S, Viailly PJ, Bertrand P, Bohers E, Maingonnat C, Jaïs JP, Tesson B, Ruminy P, Peyrouze P, Copie-Bergman C, Fest T, Jo Molina T, Haioun C, Salles G, Tilly H, Lecroq T, Leroy K, Jardin F. Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma. Genes Chromosomes Cancer. 2016 Mar;55(3):251–267.
130.
Miloudi H, Bohers É, Guillonneau F, Taly A, Gibouin VC, Viailly PJ, Jego G, Grumolato L, Jardin F, Sola B. XPO1E571K Mutation Modifies Exportin 1 Localisation and Interactome in B-cell Lymphoma. Cancers (Basel). 2020 Sep 30;12(10):2829. PMCID: PMC7600770
131.
Jardin F, Pujals A, Pelletier L, Bohers E, Camus V, Mareschal S, Dubois S, Sola B, Ochmann M, Lemonnier F, Viailly PJ, Bertrand P, Maingonnat C, Traverse-Glehen A, Gaulard P, Damotte D, Delarue R, Haioun C, Argueta C, Landesman Y, Salles G, Jais JP, Figeac M, Copie-Bergman C, Molina TJ, Picquenot JM, Cornic M, Fest T, Milpied N, Lemasle E, Stamatoullas A, Moeller P, Dyer MJS, Sundstrom C, Bastard C, Tilly H, Leroy K. Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma. Am J Hematol. 2016 Sep;91(9):923–930.
132.
Skalniak L, Mizgalska D, Zarebski A, Wyrzykowska P, Koj A, Jura J. Regulatory feedback loop between NF-kappaB and MCP-1-induced protein 1 RNase. FEBS J. 2009 Oct;276(20):5892–5905.
133.
Shin SY, Lee ST, Kim HJ, Ki CS, Jung CW, Kim JW, Kim SH. BRAF V600E and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone lymphoma cases. Ann Lab Med. 2015 Mar;35(2):257–259. PMCID: PMC4330180
134.
Louissaint A, Schafernak KT, Geyer JT, Kovach AE, Ghandi M, Gratzinger D, Roth CG, Paxton CN, Kim S, Namgyal C, Morin R, Morgan EA, Neuberg DS, South ST, Harris MH, Hasserjian RP, Hochberg EP, Garraway LA, Harris NL, Weinstock DM. Pediatric-type nodal follicular lymphoma: A biologically distinct lymphoma with frequent MAPK pathway mutations. Blood. 2016 Aug 25;128(8):1093–1100. PMCID: PMC5000844
135.
Otto C, Giefing M, Massow A, Vater I, Gesk S, Schlesner M, Richter J, Klapper W, Hansmann ML, Siebert R, Küppers R. Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma. Br J Haematol. 2012 Jun;157(6):702–708.
136.
Abate F, Ambrosio M, Mundo L, Laginestra M, Fuligni F, Rossi M, Zairis S, Gazaneo S, Falco GD, Lazzi S, Bellan C, Rocca BJ, Amato T, Marasco E, Etebari M, Ogwang M, Calbi V, Ndede I, Patel K, Chumba D, Piccaluga P, Pileri S, Leoncini L, Rabadán R. Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma. PLoS Pathogens. 2015;11.

Citing

If you use the information or data from this site, please cite

Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.